Zdrowie i gospodarka · 24/06/2021
FDA Hosts Public Workshop to Discuss PML Clinical Trial Designs
The FDA is hosting a public workshop to discuss the challenges and design considerations for developing therapeutic products for progressive multifocal leukoencephalopathy (PML), a rare and serious brain disease.